期刊文献+

肝细胞肝癌中p27^(KIP1)基因的表达及意义 被引量:1

Study on p27^(KIP1) Expression in Hepatocellular Carcinoma
下载PDF
导出
摘要 目的 探讨 p2 7KIP1与原发性肝细胞癌 (HCC)发生、发展的关系。方法 应用SABC(链霉素亲和素 生物素复合物 )免疫组化染色和mRNA原位杂交方法 ,对 5 2例肝细胞肝癌中p2 7KIP1蛋白和mRNA的表达进行了检测。结果  p2 7KIP1基因的表达主要位于肝或肝癌细胞的细胞核中 ,呈细颗粒状分布。p2 7KIP1蛋白在癌旁肝组织中的阳性细胞指数为 ( 10 .7± 7.6) % ,明显高于癌组织的 ( 1.5± 0 .9) % ,并且 p2 7KIP1蛋白表达的阳性细胞指数与HCC细胞的分化程度呈正相关。p2 7KIP1mRNA杂交阳性物呈蓝色细颗粒状 ,主要位于肝或肝癌细胞的细胞核和细胞浆中 ,mRNA阳性的细胞分布更广泛 ,但在癌旁肝组织和不同分化程度的HCC组织中 ,p2 7KIP1mRNA的阳性细胞指数差异无显著性意义。结论 p2 7KIP1蛋白与HCC的发生及细胞分级有关。 Objective To study the relationship between expression of p27 KIP1 and progression of hepatocellular carcinoma(HCC).Methods The expression of p27 KIP1 in 52 cases of HCC was detected by immunohistochemistry of strept avidin biotin complex and mRNA in situ hybridization.Results The positive cells of p27 KIP1 protein were diffused in HCC.The positive signal was localized in nuclei.The labeling index (LI) of p27 KIP1 protein was significantly higher in tumor surrounding tissues than that in tumor tissues. p27 KIP1 protein LI showed a positive correlation with the differentiation grade of HCC.The better differentiation of cancer cells, the higher LI of p27 KIP1 protein ( P <0.01).The positive cells of p27 KIP1 mRNA were also diffused in HCC.The positive signal was localized in nuclei and cytoplasm. As to the expression of p27 KIP1 at the mRNA level,there was no significant correlation with tumor surrounding tissues and stages of HCC.Conclusionp27 KIP1 protein is associated with progression and differentiation grade of hepatocellular carcinoma.
出处 《中国普外基础与临床杂志》 CAS 2003年第3期240-242,共3页 Chinese Journal of Bases and Clinics In General Surgery
关键词 肝细胞肝癌 P27^KIP1 基因 表达 Hepatocellular carcinoma Gene Gene expression
  • 相关文献

参考文献9

  • 1郭贵龙,姚榛祥.p27在甲状腺滤泡状肿瘤中的表达及其意义[J].中国普外基础与临床杂志,2001,8(5):324-325. 被引量:7
  • 2夏加增,杨继昌,张熔熔,朱正纲,尹浩然.胃癌中cyclin D1、cyclin E和P27的表达及其意义[J].中国普外基础与临床杂志,2001,8(3):148-150. 被引量:6
  • 3Lloyd RV, Erickson LA, Jin L, et al. p27^KIPI, a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers [J]. Am J Pathol, 1999; 154(2) :313.
  • 4Peng D, Fan Z, Lu Y, et al. Anti-epidexmal growth factor receptor monoclonal antibody 225 up-regulates p27^KIPI and induces G1 arrest in prostatic cancer cell line DU145^1 [J]. Cancer Res, 1996; 56(16) : 3666.
  • 5Polyak K, Kato JY, Solomon MJ, et al. p27^KIPI , a cyclin-CDK inhibitor; links transforming growth factor-beta and contact inhibition to cell cycle arrest [J]. Genes Dey, 1994; 8(1) : 9.
  • 6Tsihlias J, Kapusta LR, DeBoer G, et al. Loss of cyclin-dependent kinase inhibitor p27^KIPI is a novel prognostic factor in localized human prostate adenocarcinoma [J]. Cancer Res, 1998; 58(3) : 542.
  • 7Kawamata N, Morosetti R, Miller CW, et al. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kipl in human malignancies [J]. Cancer Res, 1995, 55(11) : 2266.
  • 8Zhang Y, Lin SC. Molecular characterization of the cyclin-dependent kinase inhibitor p27 promoter [J]. Biochim Biophys Acta,1997, 1353(3) :307.
  • 9Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas [J]. Nat Med, 1997; 3(2) :231.

二级参考文献6

  • 1[1]Lazzereschi D,Sanbuco L,Scalzo CC,et al.Cyclin D1 and cyclin E expression in malignant thyroid cells and in human thyroid carcinomas [J]. Int J Cancer,1998; 76(6)∶806
  • 2[2]Muller W,Noguchi T,Wirtz HC,et al.Expression of cell-cycle regulatory proteins cyclin D1,cyclin E,and their inhibitor p21 waf 1/cip 1 in gastric cancer [J]. J Pathol,1999; 189(1)∶186
  • 3[3]Kim SJ,Lee JB,Kim CS,et al.Cyclin D1 and p21 expression in gastric adenocarcinoma [C].3rd. International Gastric Cancer Congress, 1999∶359~360
  • 4[4]Yasui W,Akama Y,Kuniyasu H,et al.Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status [J]. J Exp Ther Oncol,1996; 1(1)∶88
  • 5[5]Yasui W,Kudo Y,Semba S,et al.Reduced expression of cyclin-dependent kinase inhibitor p27 kip1 is associated with advanced stage and invasiveness of gastric carcinomas [J].Jpn J Cancer Res,1997; 88(7)∶625
  • 6[6]Fredersdorf S,Burns J,Milne AM,et al.High level expression of p27 kip1 and cyclin D1 in some human breast cancer cells:inverse correlation between the expression of p27 kip1 and degree of malignancy in human breast and colorectal cancers [J].Proc Natl Acad Sci USA,1997; 94(12)∶6380

共引文献9

同被引文献19

  • 1Foekens JA;Peters HA;Look MP.The urokinase system of plasminogen activation and prognosisin 2780 breast cancer patients,2000.
  • 2Suzuki N;Fujioka K;Denda-Nagai K.The macrophage C-type lectin specific for galactose/N-acety lgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cells[J],2002(23).
  • 3Ogata R;Torimura T;Kin M.Increase depression of membrane type 1 oproteinase and matrix metalloproteinase-2 with tumor dedifferentiation in hepatocellular carcinoma (see comments),1999.
  • 4Saito K;Takeha S;Shibak.Clinicopathologic significance of urokinase receptor and MMPS-9-positive stromal cells in human colorectal cancer functional multiplicity of matrix degradation on hematogenous matatasis[J],2000(01).
  • 5Golderg RM;Moertel CG;Wieand HS.A phase evaluation of asomatostatin analogue(octreotide)in the treatment of patients with asymptomatic advanced colon carcinoma[J],1995(06).
  • 6Yuen MF;Poon RT;Lai CL.A randomized placebocontrolled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma[J],2002(03).
  • 7di Maio M;De Maio E;Perrone F.Hepatocellular carcinoma:systemic treatments[J],2002(Z2).
  • 8Dimitroulopoulos D;Xinopoulos D;Tsamakidis K.The role of sandcstatin LAR in treating patients with advanced hepatocellular cancer,2002(47).
  • 9Schindel DT.查看详情[J],1997(07).
  • 10Rabe C;Pilz T;Allgaier HP.Clinical outcome of a cohort of 63 patients with hepatocellular carcinoma treated with octreotide,2002(06).

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部